MAPT and Alzheimer disease: Given the above findings demonstrating MSUT2 involvement in determining susceptibility to pathological tau, combined with its role as a nuclear speckle-localized RNA-binding protein, we have begun to explore the role of RNA-binding protein-mediated pathological consequences of tauopathy in AD.